Ken Sekitani is an accomplished executive with extensive experience in the healthcare and financial sectors. Currently serving as the COO and board member of ジーエヌアイグループ since March 2024, Ken also holds positions as Executive Vice President and Board member at EPS Holdings, Inc. and Managing Corporate Officer at EPS International Holdings Co., Ltd. since late 2018. Ken's previous roles include Managing Director at KAKEN PHARMACEUTICAL CO., LTD and various leadership positions within the EPS Group, focusing on corporate strategy and operations. Notably, Ken directed operations and quality at GE Commercial Finance Japan, managing key departments. Ken holds a Bachelor's degree in Economics from The University of Tokyo.
This person is not in any teams
This person is not in any offices
EPS Corporation(formerly EPS International), a full-service Japan-headquartered CRO
EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.” Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9